Last reviewed · How we verify
IDp-120 Vehicle Gel — Competitive Intelligence Brief
phase 3
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
IDp-120 Vehicle Gel (IDp-120 Vehicle Gel) — Bausch Health Americas, Inc.. IDp-120 is a topical immunomodulatory gel formulation designed to enhance local immune response at the application site.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| IDp-120 Vehicle Gel TARGET | IDp-120 Vehicle Gel | Bausch Health Americas, Inc. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- IDp-120 Vehicle Gel CI watch — RSS
- IDp-120 Vehicle Gel CI watch — Atom
- IDp-120 Vehicle Gel CI watch — JSON
- IDp-120 Vehicle Gel alone — RSS
Cite this brief
Drug Landscape (2026). IDp-120 Vehicle Gel — Competitive Intelligence Brief. https://druglandscape.com/ci/idp-120-vehicle-gel. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab